Erdafitinib for FGFR-mutated urothelial carcinoma
The role of immunotherapy in the radical treatment of NSCLC: where are we headed?
Development of novel treatments in melanoma patients with BRAF mutations
Rovalpituzumab in small cell lung cancer (SCLC)
ESMO 2016: Press brief on the MONALEESA-2 clinical trial on breast cancer